Activation of bruton's tyrosine kinase (BTK) by a point mutation in its pleckstrin homology (PH) domain
Bruton's tyrosine kinase (BTK) is a nonreceptor tyrosine kinase critical for B cell development and function. Mutations in BTK result in X-linked agammaglobulinemia (XLA) in humans and X-linked Immunodeficiency (xid) in mice. Using a random mutagenesis scheme, we isolated a gain-of-function mut...
Gespeichert in:
Veröffentlicht in: | Immunity (Cambridge, Mass.) Mass.), 1995-05, Vol.2 (5), p.451-460 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Bruton's tyrosine kinase (BTK) is a nonreceptor tyrosine kinase critical for B cell development and function. Mutations in BTK result in X-linked agammaglobulinemia (XLA) in humans and X-linked Immunodeficiency (xid) in mice. Using a random mutagenesis scheme, we isolated a gain-of-function mutant called BTK* whose expression drives growth of NIH 3T3 cells In soft agar. BTK* results from a single point mutation In the pleckstrin homology (PH) domain, where a Glu is replaced by Lys at residue 41. BTK* shows an increase In phosphorylation on tyrosine residues and an increase in membrane targeting. Transforming activity requires kinase activity, a putative autophosphorylation site, and a functional PH domain. Mutation of the SH2 or SH3 domains did not affect the activity of BTK*. Expression of BTK* could also relieve IL-5 dependence of a B lineage cell line. These results show that transformation activation and regulation of BTK are critically dependent on the PH domain. |
---|---|
ISSN: | 1074-7613 1097-4180 |
DOI: | 10.1016/1074-7613(95)90026-8 |